Switch to the original HML Online view

Hospital Medicines List

Enter at least 4 characters

0 matches for: 'imatinib mesilate' in the Therapeutic Groups

1 results showing for: 'imatinib mesilate'

  • Restricted. Tab 100 mg
    • Brand Glivec
    • Pharmacode2123606
    • Subsidy $2400.00
    • Measure / Qty per 60
    RS1402 - Imatinib mesilate - Tab 100 mg
  • Cap 100 mg - 1% DV Jun-21 to 2023 (HSS)
    • Brand Imatinib-Rex
    • Pharmacode2594315
    • Subsidy $58.23
    • Measure / Qty per 60
  • Cap 400 mg - 1% DV Jun-21 to 2023 (HSS)
    • Brand Imatinib-Rex
    • Pharmacode2594323
    • Subsidy $84.79
    • Measure / Qty per 30

The Glivec brand of imatinib mesilate (supplied by Novartis) is fully subsidised under Special Authority for patients with unresectable and/or metastatic malignant GIST only, see SA1460 in Section B of the Pharmaceutical Schedule

  • Rectangle page icon symoblising a PDF. PDF
  • Two duplicate pages icon. Click to copy
  • Restriction. Restriction
  • HSS Hospital Supply Status
  • PSS Principal Supply Status
  • dv DV Limit Gives the maximum volume that can be purchased of other brands
  • B Bolded Pharmacode means that the product is to be delisted soon